🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Fantastic presentations by Sumanta K. Pal, MD, FASCO Jean Hoffman-Censits in histology subtypes of bladder cancer & non-clear cell RCC! Major progress but way to go: need prospective trials via collaborations! Pavlos Msaouel ECOG-ACRIN Cancer Research Group Shilpa Gupta Global Society of Rare GU Tumors Philippe spiess Karima Oualla, MD,MSc ASCO OncoAlert #ASCO24

Check out our new publication: Enfortumab-Vedotin Related Cutaneous Toxicity Correlates with Overall Survival in Patients with Urothelial Cancer Jean Hoffman-Censits David McConkey Andres Matoso Johns Hopkins Greenberg Bladder Cancer Institute nam02.safelinks.protection.outlook.com/?url=https%3A%…

#WorldRefugeeDay comes but once a year, but 120 million refugees around the world need access to health care every day. We thank host countries for their effort to provide care to everyone in need. We thank partners for their collaboration to protect the most vulnerable.

Great opportunity for trainees of all levels interested in research. Great scientists from all around the world including Petros Grivas 🇬🇷🇬🇷

Drag Bingo in Baltimore 🌈🌈 Celebrating love and creativity with Johns Hopkins Postdoctoral Association (JHPDA) and DPAC ❤️🩷🩵🧡💜💛

8- updates on Recent adv in managing non-urothelial bladder cancer subtypes, often with worse prognosis than UC Txs are typically extrapolated from UC #bladdercancer #oncology Evangelia (Elina) Vlachou, MD Jean Hoffman-Censits ASCO #ASCOEdBook 👉 ascopubs.org/doi/pdf/10.120…

Thank you UroToday.com for highlighting our work with Ronac Mamtani Jean Hoffman-Censits and Vivek Nimgaonkar on Racial Differences in Cutaneous Events Among Patients Receiving Enfortumab Vedotin urotoday.com/recent-abstrac…

Lever de rideau 💦 La délégation grecque ouvre la parade des athlètes, comme le veut la tradition. - Curtain up 💦 The Greek delegation opens the athletes' parade, as per tradition dictates. 📸 Getty /Jared C. Tilton / Lars Baron #Paris2024

📣📣Are you an IMG at Hopkins? Don’t miss this amazing opportunity to learn effective strategies for residency personal statement. Johns Hopkins Postdoctoral Association (JHPDA) Doctoral Life Design Studio

maintenance #avelumab: OS was statistically significantly longer in patients with TMB ≥10 vs patients with TMB <10 (61 vs. 17 months; HR = 0.2 [95% CI, 0.05-0.6], P = .006) and numerically longer in those with MSI-H (mOS NR) versus MSI-S (mOS 24 months). (5/7)

Look forward to seeing you all tomorrow for a fruitful discussion and of course 🍕🍕🍕 JHU Diversity Postdoctoral Alliance Committee Nacia Liapodimitri, MD

Honored/humbled to be a candidate for ASCO nominating committee after serving in several committees, leadership development program, etc. There are excellent candidates in all categories! We encourage active members to vote & help shape future of ASCO society.asco.org/about-asco/asc…

Many of us physicians are the safeguards for a health system that often doesn’t fulfill the care it should equitably, equally. So, we will continue to practice medicine in the hospital & promote health where we can in the community. Like we are doing today And will do tomorrow🙏

Day 2️⃣ ASCO #GU25 Don’t miss the poster C17 on outcomes with EV with or without Pembro in Upper tract #urothelialcancer presented by Evangelia (Elina) Vlachou, MD

Padcev Plus Keytruda Shows Promise for Upper Tract Urothelial Carcinoma Lesions Evangelia (Elina) Vlachou, MD Johns Hopkins Medicine ASCO #GU25 #UrothelialCarcinoma curetoday.com/view/padcev-pl…

It was a great pleasure to present our work with Jean Hoffman-Censits on EV & EV/P primary tumor response in pts with UTUC at #asco #GU25 This meeting is one of my favorite times of the year… seeing old friends and making new ones! 🤩 Petros Grivas Dimitra R. Bakaloudi MD, MS, MPA Ardit Feinaj, MD Stepan M. Esagian, MD

Incredibly proud of Evangelia (Elina) Vlachou, MD for matching at The Osler Medical Residency! She’s got a bright future ahead in oncology—can’t wait to see all she’ll accomplish! Jean Hoffman-Censits Johns Hopkins Kimmel Cancer Center

This week we celebrated my 2-year research fellowship at Johns Hopkins Kimmel Cancer Center and my residency match into The Osler Medical Residency. Big thank you to all those who supported me and believed in me and most of all to my mentor Jean Hoffman-Censits. This would have never been possible without you!

Excited for the next 3 years at Johns Hopkins UH Residents The Osler Medical Residency with the most dedicated and intelligent group of doctors!

Happy July 1 from the Osler Medical Residency! Excited to see our amazing ACSs lead this incredible group of future leaders in medicine—the next generation of Oslerian physicians! Much #oslerpride